Understand how SHBG affects the relationship between total and free testosterone, and why clinicians interpret these results together.
Total testosterone describes the overall amount in a blood sample while free testosterone describes the unbound portion, and SHBG helps clinicians decide whether the total result needs additional context.
This article is for informational purposes and is not medical advice. A qualified clinician should interpret personal hormone results and make decisions about diagnosis or treatment.
A total-testosterone result answers a broad laboratory question: how much testosterone is present in the blood sample? It does not separately describe the free-testosterone level. That distinction matters because sex hormone-binding globulin, usually shortened to SHBG, binds testosterone in circulation.
The total result therefore gives information about hormone amount without fully describing its relationship to the unbound portion. Reading the total value and assessing free testosterone are related tasks, but they are not interchangeable. SHBG provides context for understanding the connection between them.
For a reader reviewing a laboratory report, the first useful distinction is between the result itself and its clinical interpretation. The number describes the sample. Its meaning depends on the clinical picture and whether a condition may affect SHBG. Our explanation of why the total measurement leaves part of the picture unresolved covers this binding relationship in more detail.
A men's lab-panel education source quotes an Endocrine Society recommendation to obtain free testosterone when total testosterone is near the lower limit of normal or when a condition alters SHBG. The recommendation identifies equilibrium dialysis or an accurate calculation as suitable methods.
This is a selective use of free-testosterone assessment. It does not make free testosterone a routine replacement for total testosterone in every case. Instead, it identifies situations in which the overall amount may need another measure to support interpretation.
A result close to the lower end of the laboratory range therefore brings a specific question into the consultation: would free testosterone help explain this result? The same question is relevant when a health condition may alter SHBG, even though the starting concern is about total testosterone.
The important distinction is between adding information and replacing information. Total testosterone remains part of the picture. Free testosterone addresses a related question that becomes especially relevant under the circumstances described in the quoted recommendation.
Free testosterone refers to testosterone that is not bound in circulation. It describes a different aspect of the sample from the total measurement. Rather than reporting the overall amount, it focuses on the unbound portion whose relationship to total testosterone can shift when SHBG changes.
The difference is mechanical rather than competitive. Total and free testosterone are not rival tests trying to produce the same answer. They describe related features of circulating testosterone, and the binding context helps explain why their interpretation may differ.
This distinction also changes how a report should be discussed. A free-testosterone result is not simply another version of the total result. Understanding which measure is being reported is part of understanding what question the assessment addresses. Testostra's guide to the differences between testosterone measures provides additional terminology for that conversation.
According to the same clinical information source, free testosterone can be measured using equilibrium dialysis. An alternative is an accurate calculation using total testosterone, SHBG and albumin. These are the approaches identified in the quoted Endocrine Society recommendation.
A calculation brings related laboratory information together rather than relying on SHBG alone. Its inputs matter because the calculation is intended to assess free testosterone through the relationship between testosterone and the proteins included in the formula. A calculated result and a measured result should therefore be described accurately during the clinical discussion.
For the reader, a useful question is straightforward: was free testosterone measured or calculated? If it was measured, the method is relevant. If it was calculated, the clinician can explain which results were used and how the approach relates to the quoted recommendation.
The supplied recommendation does not provide a universal free-testosterone cutoff or a complete diagnostic protocol. Its practical contribution here is narrower: it identifies when free-testosterone assessment is useful and names acceptable approaches. Personal interpretation still requires qualified care.
SHBG is a binding protein, not another name for testosterone. Because it binds testosterone in circulation, changes in SHBG can alter the relationship between the overall testosterone amount and the free portion. A total value alone therefore does not fully describe the free-testosterone level.
This explains why the clinical question is not simply whether SHBG is high or low. It is whether the binding context helps explain the relationship between the testosterone measurements. The clinician weighs the values together rather than treating SHBG as a substitute for either one.
Clinical education material on free-testosterone calculation describes several associations between SHBG and health or body-composition factors:
These associations identify relevant context for a consultation. They do not mean that every person with one of these conditions will have the same SHBG pattern. Nor does a single SHBG result establish which condition is responsible for it.
Medication history and changes in body weight are also relevant to discussing a testosterone result. The research supports bringing that information into the clinical review. It does not support predicting a particular hormone response for an individual man or changing medication independently.
This is the central limit of interpreting SHBG: a high or low value does not, on its own, establish testosterone deficiency. Associations are clues for clinical review rather than proof of cause. The wider picture determines how much weight the result should carry.
For readers facing apparently mixed findings, the more useful starting point is the relationship between the measurements. Our discussion of contrasting SHBG and testosterone patterns develops that approach without treating one marker as the whole answer.
In a 2026 statement concerning a Defense Health Agency guideline, the Endocrine Society noted that obesity can accompany low total testosterone. It also supported obesity treatment and weight-management care in that setting. This places the hormone result within a broader health discussion.
That statement concerns treatment policy. It does not establish how to interpret SHBG in an individual patient. The policy point and the laboratory point are related, but they answer different questions: one concerns care priorities while the other concerns the meaning of particular measurements.
Keeping those questions separate prevents a shortcut from an association to a personal treatment conclusion. Obesity may be relevant to the discussion of total testosterone and SHBG. Determining its significance for an individual belongs with the clinician reviewing the full clinical picture.
The most useful discussion is not a search for the single most important hormone number. It is a review of what each measurement contributes. The supplied recommendation and clinical education material support several focused questions:
These questions do not create a personal testing or treatment protocol. They organize the conversation around the evidence already available. The purpose is to understand why an additional measurement is being considered and what it adds to the clinical assessment.
A useful explanation from the clinician should connect the total result with any free-testosterone assessment and the SHBG context. It should also connect those findings with the concern that prompted testing. That keeps the discussion centered on a medical question rather than on collecting more laboratory values for their own sake.
Total testosterone describes the overall amount, free testosterone describes the unbound portion, and SHBG helps clinicians understand their relationship within the wider clinical picture.
Responsibility for interpreting SHBG alongside testosterone remains with a qualified clinician, while Testostra supplies evidence-led explanations for men preparing for that discussion. Its biomarker coverage helps readers distinguish the overall testosterone measure from the free fraction and understand SHBG's relevance, with a firm boundary between education and individual medical decisions.
Testostra follows testosterone research, clinical guidance and emerging evidence without turning general information into personal treatment advice.
Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.
Contact Testostra